Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
NEW YORK, Nov. 22, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder law firm, has launched an investigation into whether the board members of Cision Ltd....
-
NEW YORK, June 18, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. is investigating potential claims against the board of directors of C&J Energy Services, Inc. (NYSE: CJ) on behalf of...
-
NEW YORK, June 11, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. is investigating potential claims against the board of directors of Shutterfly, Inc. (NASDAQ: SFLY) on behalf of...
-
NEW YORK, June 09, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. is investigating potential claims against certain officers and directors of Quest Diagnostics Incorporated (NYSE: DGX). ...
-
NEW YORK, June 04, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. is investigating potential claims against certain officers and directors of Care.com, Inc. (NYSE: CRCM). Click here to...
-
NEW YORK, June 04, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. is investigating potential claims against the board of directors of Presidio Bank (Other OTC: PDOB) on behalf of Presidio...
-
NEW YORK, June 04, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. is investigating potential claims against the board of directors of Presidio Bank (Other OTC: PDOB) on behalf of Presidio...
-
NEW YORK, June 03, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. is investigating potential claims against the board of directors of Cypress Semiconductor Corporation (NASDAQ: CY) on...
-
NEW YORK, May 31, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. is investigating potential claims against certain officers and directors of Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM). ...
-
NEW YORK, May 31, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. is investigating potential claims against certain officers and directors of Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM). ...